Delivery Order SPE2DB22D3501-SPE2DB25FWP57
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9ML) with a firm fixed price structure. The contract, awarded on July 16, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.15 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9mL) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's broader contract vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (0.9 mL) under contract 4567983925. This firm fixed-price delivery order, issued on April 21, 2025, with an ultimate completion date of May 12, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency awarded a $3,141.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9 mL) with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,041.25 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25, 6-month to 4-year formulation, 0.9 mL) with a firm fixed price structure. The contract, issued on June 24, 2025, with an ultimate completion date of July 16, 2025, represents a non-competitive, non-set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under a firm fixed-price contract with a ceiling value of $1,570.70. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
- This delivery order, valued at $1,570.70, was awarded on July 14, 2025, to AmerisourceBergen Drug Corp for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under an Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child delivery...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award issued by the Defense Logistics Agency (DLA) provides Amerisourcebergen Drug Corp with a Firm Fixed Price Delivery Order for the supply of 0.9ML Pfizer COVID-19 vaccines for the 2024-2025 period, with an ultimate completion date of October 10, 2024. The contract has a ceiling value of $1,135.77 and does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to deliver these critical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,135.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses in 0.9 mL vials. The contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP57Delivery Order
The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,570.70 for Pfizer COVID-19 vaccines (2024-25 formulation, 0.9ml) with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order through its established federal medical procurement infrastructure that serves military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent performance in competitively awarded federal contracts, combined with its extensive pharmaceutical distribution capabilities across multiple therapeutic domains, positions it as a critical vendor within the Defense Health Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/25/25 |